Schizophrenia Research and Treatment
Overview
Schizophrenia Research and Treatment is a scientific journal, published by Wiley since 2010 in English. The journal's country of origin is United States.
Details
Details
Abbr.
Schizophr Res Treatment
Publisher
Wiley
Start
2010
End
2023
p-ISSN
2090-2085
e-ISSN
2090-2093
Country
United States
Language
English
Metrics
Metrics
h-index / Ranks: 14180
11
SJR / Ranks: 6763
661
CiteScore / Ranks: 9632
2.50
Recent Articles
1.
Kule M, Kaggwa M
Schizophr Res Treatment
. 2023 Feb;
2023:7035893.
PMID: 36778520
Background: There has been a recent transition from typical to atypical antipsychotics in managing schizophrenia. This has been attributed to the acute side effects experienced by patients on typical antipsychotics...
2.
Marthoenis M, Martina M, Alfiandi R, Dahniar D, Asnurianti R, Sari H, et al.
Schizophr Res Treatment
. 2022 Mar;
2022:1381542.
PMID: 35265376
Background: Antipsychotics exert metabolic side effects, and prolonged treatment with antipsychotics causes changes in body weight and muscle composition. Nevertheless, reports on the changes in body composition of patients with...
3.
Cigarette Smoking and Schizophrenia: Etiology, Clinical, Pharmacological, and Treatment Implications
Ding J, Hu K
Schizophr Res Treatment
. 2021 Dec;
2021:7698030.
PMID: 34938579
Recent data suggests that the prevalence of smoking in schizophrenia remains high. While reports suggest that smoking increases the risk of developing schizophrenia, the potential causative role of smoking in...
4.
Sathienluckana T, Tiangpattanawong P, Chaiyasukthananoan K, Jittayanan P, Sawetwangsing H, Puchsaka P
Schizophr Res Treatment
. 2021 Dec;
2021:8403986.
PMID: 34868682
Background: Long-acting injectable (LAI) antipsychotics are used as a monotherapy in patients with schizophrenia. However, the combination of LAI and oral antipsychotics is commonly used in clinical practice, despite there...
5.
Zhilyaeva T, Piatoikina A, Bavrina A, Kostina O, Zhukova E, Shcherbatyuk T, et al.
Schizophr Res Treatment
. 2021 Oct;
2021:7721760.
PMID: 34707909
A wide range of studies have demonstrated that hyperhomocysteinemia is associated with the risk of schizophrenia, but currently available assumptions about the direct involvement of homocysteine (Hcy) in the pathogenesis...
6.
Ayalew M, Defar S, Reta Y
Schizophr Res Treatment
. 2021 Apr;
2021:6662765.
PMID: 33868728
Background: People with schizophrenia (PWS) are at greater risk of suicide. However, suicide behaviors that occur in PWS are often overlooked, inadequately characterized, and not consistently integrated into treatment. Despite...
7.
Okada H, Hirano D, Taniguchi T
Schizophr Res Treatment
. 2021 Mar;
2021:8864352.
PMID: 33688435
Negative symptoms of schizophrenia have generally been defined using five factors; however, few studies have examined the relationship between these five factors and functional outcomes. In addition, there is no...
8.
Chen J, Mize T, Wu J, Hong E, Nimgaonkar V, Kendler K, et al.
Schizophr Res Treatment
. 2020 Aug;
2020:1638403.
PMID: 32774919
Schizophrenia is a complex disorder with many comorbid conditions. In this study, we used polygenic risk scores (PRSs) from schizophrenia and comorbid traits to explore consistent cluster structure in schizophrenia...
9.
Bakshi K, Kemether E
Schizophr Res Treatment
. 2020 Jun;
2020:5176834.
PMID: 32566292
We used whole human genome microarray screening of highly enriched neuronal populations from two thalamic regions in postmortem samples from subjects with schizophrenia and controls to identify brain region-specific gene...
10.
Kibru B, Tesfaw G, Demilew D, Salelew E
Schizophr Res Treatment
. 2020 Apr;
2020:3934680.
PMID: 32274213
Background: The comorbidity of social anxiety disorder is very common in schizophrenia patients and affects almost all age groups. This social anxiety disorder negatively impacts the quality of life, medication...